NEW YORK, Aug 2 (GenomeWeb News) - Strand Genomics said today that it has formed a collaboration with Japanese pharmacogenomics services company MediBic to provide bioinformatics and data mining solutions in Japan.
Under the terms of the deal, Strand and MediBic will jointly develop products and technologies for their drug discovery and development customers. Additionally, they will provide consulting in the areas of genomics, proteomics, clinical studies, predictive ADME/toxicology, and other pharmaceutical research and development areas, said Bangalore, India-based Strand.
Financial terms of the arrangement were not disclosed.
"One of MediBic's [goals] has been to strengthen its informatics and pharmacogenomics capabilities through key strategic partnerships," Yasuhiro Hashimoto, president and CEO of MediBic, said in a statement. "This partnership provides us with the platform to offer an integrated discovery and development system."